Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Apr 26, 2012; 4(4): 90-102
Published online Apr 26, 2012. doi: 10.4330/wjc.v4.i4.90
Published online Apr 26, 2012. doi: 10.4330/wjc.v4.i4.90
Role of advanced glycation end products in cardiovascular disease
Zeinab Hegab, Stephen Gibbons, Ludwig Neyses, Mamas A Mamas, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9WL, United Kingdom
Ludwig Neyses, Mamas A Mamas, Manchester Heart Centre, Manchester Royal Infirmary, Manchester M13 9WL, United Kingdom
Author contributions: Hegab Z prepared first draft; Gibbons S and Neyses L provided intellectual content and contributions to manuscript revisions; Mamas MA developed idea for manuscript, intellectual content and major contribution to revisions.
Correspondence to: Dr. Mamas A Mamas, Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, United Kingdom. mamasmamas1@yahoo.co.uk
Telephone: +44-796-7102675 Fax: +44-161-2761234
Received: February 11, 2012
Revised: April 4, 2012
Accepted: April 10, 2012
Published online: April 26, 2012
Revised: April 4, 2012
Accepted: April 10, 2012
Published online: April 26, 2012
Core Tip